MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z

Ultrasound-guided treatment of action tremor of the upper limb with botulinum toxin

M.C Costa, P. Pita-Lobo, C. Figueiredo, L. Rebordão, A. Cadete (Amadora, Portugal)
Understanding characteristics, healthcare resource use and costs of patients with Parkinson’s disease prior to and after diagnosis of cognitive impairment

J. Chandler, R. Nair, E. Ferries, L. Munsie, T. Changamire, N. Patel, K. Biglan (Louisville, KY, USA)
Undiagnosed Neuropathology In Fallers: Findings from a 10-year Autopsy Series

C. Fearon, C. Hunt, J. Lorigan, A. Beausang, J. Cryan, M. Farrell, F. Brett (Dublin, Ireland)
Unilateral thalamic Vim and GPi stimulation for the treatment of Holmes’ tremor caused by trauma

O. Dogu, V. Hamzaoglu, H. Ozalp (Mersin, Turkey)
Unique speech change pattern in Parkinson’s disease after GPi deep brain stimulation

S. Chiu, T. Tsuboi, M. Burns, J. Legacy, K. Moore, K. Hegland, N. Herndon, A. Ramirez-Zamora, K. Foote, M. Okun, L. Almeida (Gainesville, FL, USA)
Unlocking dystonia from Parkinson’s disease (PD) with directional deep brain stimulation (DBS)

R. Vaden, A. Nakhmani, C. Hurt, C. Gonzalez, B. Guthrie, H. Walker (Birmingham, AL, USA)
Unmet psychological needs of People with Parkinson’s disease

M. Turner, S. Chobanova, C. Grose, C. thomas, B. Mohamed (Cardiff, United Kingdom)
Unraveling neural oscillatory changes due to STN Coordinated Reset Deep Brain Stimulation in the MPTP Non-Human Primate Model of Parkinsonism

J. Bore, B. Campbell, H. Cho, M. Newcomb, R. Faulhammer, A. Machado, K. Baker (Cleveland, OH, USA)
Unraveling the role of amylin oligomers in synucleinopathies

I. Martinez Valbuena, R. Valenti Azcarate, C. Caballero, I. Marcilla Garcia, I. Amat-Villegas, J. Sanchez, G. Marti-Andres, L. Armengou, M.R Luquin Piudo (Pamplona, Spain)
Uptake in Directional Stimulation and Primary Cell Longevity in Deep Brain Stimulation of Globus Pallidus Pars Interna for Parkinson’s Disease

C. Wu, C. Matias, S. Pallavaram, A. Sharan, T. Liang (Philadelphia, PA, USA)
Upward Gaze Palsy in SCA3: a valuable semiological sign

G. Franklin, F. Nascimento, A. Meira, C. Camargo, H. Teive (Curitiba, Brazil)
Urinary Symptoms and Parkinson’s Disease: The Patient’s Perspective

J. Wertheimer, B. Reynolds, C. Walton, J. McNamara, T. Hamran, S. Freedland (Los Angeles, CA, USA)
Usability assessments in patients with Parkinson’s disease: The foundation for a holistic telemedical solution (TelePark)

J. Bendig, M. Prieto-Jarabo, A. Koppitz, B. Falkenburger, H. Reichmann, K. Löwenbrück (Dresden, Germany)
Use in Clinical Practice of a Personalised and Long-term Monitoring Device for Parkinson´s Disease: STAT-ON

D. Santos García, N. López Ariztegui, E. Cubo, A. Vinagre Aragón, R. García Ramos, C. Borrué, G. Fernández Pajarín, N. Caballol, I. Cabo, J. Barrios López, J. Hernández Vara, M.A Avila, C. Gasca Salas, S. Escalante, P. Manrique, R. Pérez Noguera, M. Álvarez Sauco, M. Sierra, M.G Monje, A. Sánchez Ferro, S. Novo, F. Alonso, D. Macías, I. Legarda, A. Rojo, I. Fernández, M.T Buongiorno, P. Pastor, P. García Ruíz (A Coruña, Spain)
Use of a new Stimulation Field Visualization Tool in Parkinson’s Disease Subjects Treated with Subthalamic Nucleus Deep Brain Stimulation (sub-analysis from INTREPID RCT)

P. Prakash, D. Romero, M. Volz, P. Starr, S. Wang, M. San Luciano, N. Galifianakis, R. Jain, J. Ostrem (San Francisco, CA, USA)
Use of Botulinum Toxin: Experience in a Cohort of Essential Tremor Patients

C. Shah, F. Jamal, A. Sarwar, G. Jackson (Houston, TX, USA)
Use of Figurative Language in Describing OFF Periods in Parkinson’s Disease

B. Edison, S. Mantri, M. Daeschler, C. Kopil, C. Marras, S. Kahl, L. Chahine (Pittsburgh, PA, USA)
User experience of body-worn sensors: perception of patients and health professionals for Parkinson’s disease at home follow-up

C. Virbel-Fleischman, Y. Rétory, S. Hardy, J.C Corvol, D. Grabli (Paris, France)
Using a Delphi process to inform the design of disease modifying trials in Parkinson’s disease

M. Zeissler, R. Windle, K. McFarthing, K. Raphael, G. Rafaloff, C. Carroll (Plymouth, United Kingdom)
Using increase in Impedance as a pointer for an early detection of DBS hardware infection

H. Singh, N. Sawal, V. Gupta, V. Gupta, A. Beri (Chandigarh, India)
Using machine learning methods to explore gait features associated with freezing of gait in Parkinson’s Disease

M. Amboni, C. Ricciardi, C. De Santis, G. Ricciardelli, G. Improta, M. Cesarelli, P. Barone (Baronissi (Salerno), Italy)
Using mindfulness to improve self-awareness in Parkinson’s disease patients – preliminary results of a randomized controlled trial

T. Buchwitz, F. Maier, A. Greuel, C. Eggers (Marburg, Germany)
Using of GcMAF in patient from Uzbekistan with MS and a concomitant liver cirrhosis due to Hepatitis B

DrD. Mirzaeva (Tashkent, Uzbekistan)
Using telemedicine and wearable technology to establish a virtual clinic for people with Parkinson’s

L. Evans, B. Mohamed, C. Thomas (Cardiff, United Kingdom)
Utility of deep brain stimulation remote programming for Parkinson’s disease during the COVID-19 outbreak

CC. Zhang, K.W Zhu, Z.Y Lin, B.M Sun, D.Y Li (Shanghai, China)
Utility of multigene panel testing for diagnosing parkinsonism and dystonia in a large cohort of >500 patients

H. Zghal Elloumi, M. Stosser, A. Lindy (Gaithersburg, MD, USA)
Utility of Tremor Electrophysiology Studies in Patients with Mixed Functional and Organic Tremor

L. Jackson, A. Hassan, J. Bower, E. Coon, B. Klassen, F. Ali (Rochester, MN, USA)
Utility of VMAT2 inhibitors in management of stereotypy in children: a series of six patients

M. Hull, M. Parnes (Houston, TX, USA)
Utility Value Analysis For Patients With Essential Tremor Receiving Magnetic-resonance Image-guided Focused Ultrasound Treatment: Three Years Of Follow-Up

L. Richard, J. Mañez-Miró, W. Ghosh, I. Chatzidaki, B. Ostrander, R. Martínez-Fernández (Tirat Carmel, Israel)
Utilization of a Visualization Software Tool for Deep Brain Stimulation Programming in a Subset of Subjects with Parkinson’s Disease Who Participated in the INTREPID Randomized Clinical Trial

M. Tagliati, L. Chen, R. Jain (Los Angeles, CA, USA)
Utilization of New Visualization Software for Deep Brain Stimulation Programming Using a Multiple-Source, Constant-Rechargeable System

J. Aldred, L. Chen, R. Jain (Spokane, WA, USA)

Jump to: View All • a b c d e f g h i j k l m n o p q r s t [u] v w x y z